Fujifilm Holdings Corp. will start a clinical study of the antiviral drug Avigan in Kuwait as early as this month in collaboration with an Indian partner company, sources close to the matter said Saturday.India's Dr. Reddy's Laboratories Ltd. is expected to mainly conduct the clinical study involving up to 1,000 people to assess its effectiveness, according to the sources.Earlier this month, Fujifilm said it had granted exclusive rights to Dr. Reddy's to develop, produce and sell the potential COVID-19 treatment drug overseas, along with Dubai-based Global Response Aid.Avigan has been seen …READ FULL ARTICLE